Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Moleculin Biotech ( (MBRX) ) has issued an update.
Moleculin Biotech, Inc. announced the use of a corporate presentation as part of its communication strategy, which is now available on their website. This presentation is being shared for informational purposes and will not be filed under the Securities Exchange Act, which may impact how stakeholders and investors perceive the company’s communications.
More about Moleculin Biotech
YTD Price Performance: 1.13%
Average Trading Volume: 51,114
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $5.71M
See more data about MBRX stock on TipRanks’ Stock Analysis page.
